1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Sundrug Co.,Ltd.

Sundrug Co.,Ltd.

SDGCF
Sundrug Co.,Ltd.US flagOther OTC
28.18
USD
- -
- -
3.30BMarket Cap

Total Valuation

Sundrug Co.,Ltd. carries a market capitalization of 3.30B, placing it among publicly traded companies globally. Its enterprise value stands at 444.77B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.30B
Enterprise Value444.77B

Share Statistics

Sundrug Co.,Ltd. currently has 116.97M shares outstanding.

Shares Outstanding116.97M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Sundrug Co.,Ltd. trades at a trailing price-to-earnings ratio of 31.43. The price-to-sales ratio is 1.25, and the price-to-book ratio stands at 1.83.

PE Ratio31.43
PS Ratio1.25
PB Ratio1.83
P/TBV Ratio1.88
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Sundrug Co.,Ltd. trades at an EV/EBITDA multiple of 21.81 and an EV/FCF ratio of 33,882.20. The EV/Sales ratio of 1.17 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.81 provides insight into valuation relative to core operating earnings.

EV / Sales1.17
EV / EBITDA21.81
EV / EBIT21.81
EV / FCF33,882.20

Financial Position

Sundrug Co.,Ltd. maintains a current ratio of 1.74, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.20, indicating elevated leverage, while an interest coverage ratio of 1,132.83 demonstrates limited ability to service its debt obligations.

Current Ratio1.74
Quick Ratio0.54
Debt / Equity13.20
Debt / EBITDA1.69
Interest Coverage1,132.83

Financial Efficiency

Sundrug Co.,Ltd. posts a return on equity of 6.01 and a return on invested capital of 5.37.

Return on Equity (ROE)6.01
Return on Assets (ROA)3.82
Return on Invested Capital (ROIC)5.37
Return on Capital Employed (ROCE)5.63
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.16

Taxes

Over the trailing twelve months, Sundrug Co.,Ltd. has paid 5.60B in income taxes, reflecting an effective tax rate of 27.07.

Income Tax5.60B
Effective Tax Rate27.07

Stock Price Statistics

Sundrug Co.,Ltd.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 28.18, while the 200-day moving average is 28.18.

Beta (5Y)N/A
52-Week Price Change0%
50-Day Moving Average28.18
200-Day Moving Average28.18
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Sundrug Co.,Ltd. generated 380.07B in revenue and converted that into 15.07B in net income, yielding earnings per share of 128.87. EBITDA reached 20.39B, while operating income came in at 20.39B.

Revenue380.07B
Gross Profit96.37B
Operating Income20.39B
Pretax Income20.67B
Net Income15.07B
EBITDA20.39B
EBIT20.39B
Earnings Per Share (EPS)128.87

Balance Sheet

Sundrug Co.,Ltd. holds 63.39B in cash and equivalents against 34.42B in total debt, resulting in a net debt position of -28.98B. Total book value stands at 258.81B, with working capital of 86.10B providing operational flexibility.

Cash & Cash Equivalents63.39B
Total Debt34.42B
Net Debt-28.98B
Equity (Book Value)258.81B
Book Value Per Share2,212.83
Working Capital86.10B

Margins

Sundrug Co.,Ltd. operates with a gross margin of 25.36, reflecting its pricing power and cost economics. The operating margin of 5.37 and net profit margin of 3.97 provide insight into operational efficiency.

Gross Margin25.36
Operating Margin5.37
Pretax Margin5.44
Profit Margin3.97
EBITDA Margin5.37

Stock Splits

Sundrug Co.,Ltd.'s most recent stock split took place on March 29, 2017 with a 1:2 split ratio.

Last Split Date3/29/2017
Split Ratio1:2

Scores

Sundrug Co.,Ltd. posts an Altman Z-Score of 3.99, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.99